Evolution of the Average Target: FibroBiologics, Inc.

Evolution of the Target Price: FibroBiologics, Inc.

Changes in Analyst Recommendations: FibroBiologics, Inc.

6885812bbc26.SyGLhMBLuyvmbldAEcN3ARXdQfZQnvIzhxenuvtkd6Y.O2D-spoM_0zRPiEOU5sHbSOMA78iwap7zmfp6stdAJc9Vrz-pxnwT4sxHg~05cde401056e4226d2265ff59bdd805e

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+1,472.33%
+16.73%
+24.29%
+79.89%
+35.55%
+26.41%
+22.58%
-15.4%
+8.66%
-9.11%
Average +166.19%
Weighted average by Cap. +23.59%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.8516USD
Average target price
13.50USD
Spread / Average Target
+1,485.25%
High Price Target
19.00USD
Spread / Highest target
+2,131.09%
Low Price Target
8.000USD
Spread / Lowest Target
+839.41%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

HC Wainwright
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.8516USD
Average target price
13.50USD
Spread / Average Target
+1,485.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FBLG Stock
  4. Consensus FibroBiologics, Inc.